NZ191847A - Stabilized pharmaceutical solutions of erythromycin - Google Patents

Stabilized pharmaceutical solutions of erythromycin

Info

Publication number
NZ191847A
NZ191847A NZ191847A NZ19184779A NZ191847A NZ 191847 A NZ191847 A NZ 191847A NZ 191847 A NZ191847 A NZ 191847A NZ 19184779 A NZ19184779 A NZ 19184779A NZ 191847 A NZ191847 A NZ 191847A
Authority
NZ
New Zealand
Prior art keywords
erythromycin
pharmaceutical solutions
stabilized pharmaceutical
stabilized
solutions
Prior art date
Application number
NZ191847A
Other languages
English (en)
Inventor
H Takruri
J Chavers
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ191847A publication Critical patent/NZ191847A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ191847A 1978-10-20 1979-10-15 Stabilized pharmaceutical solutions of erythromycin NZ191847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95315978A 1978-10-20 1978-10-20

Publications (1)

Publication Number Publication Date
NZ191847A true NZ191847A (en) 1982-05-31

Family

ID=25493654

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ191847A NZ191847A (en) 1978-10-20 1979-10-15 Stabilized pharmaceutical solutions of erythromycin

Country Status (13)

Country Link
EP (1) EP0010437B1 (enrdf_load_stackoverflow)
JP (1) JPS5557519A (enrdf_load_stackoverflow)
AU (1) AU529422B2 (enrdf_load_stackoverflow)
BE (1) BE879471A (enrdf_load_stackoverflow)
CA (1) CA1129772A (enrdf_load_stackoverflow)
CH (1) CH642544A5 (enrdf_load_stackoverflow)
DE (1) DE2967163D1 (enrdf_load_stackoverflow)
FR (1) FR2439016A1 (enrdf_load_stackoverflow)
GB (1) GB2031728B (enrdf_load_stackoverflow)
IE (1) IE49086B1 (enrdf_load_stackoverflow)
LU (1) LU81799A1 (enrdf_load_stackoverflow)
NZ (1) NZ191847A (enrdf_load_stackoverflow)
ZA (1) ZA795492B (enrdf_load_stackoverflow)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
ATE84667T1 (de) * 1986-01-31 1993-02-15 Whitby Research Inc Hautpenetration verbessernde zusammensetzungen.
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
FI883338A7 (fi) * 1987-07-16 1989-01-17 Bristol Myers Squibb Co Doksorubisiinihydrokloridin vesiliuoksia
FI883337L (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンe1含有の軟膏剤
DE19549794B4 (de) * 1994-10-26 2009-07-30 Novartis Ag Pharmazeutische Zusammensetzungen
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
RU2161955C1 (ru) * 1999-07-16 2001-01-20 Эпштейн Олег Ильич Способ изменения физико-химических или физико-химических и биологических свойств вещества
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne

Also Published As

Publication number Publication date
DE2967163D1 (en) 1984-09-13
CA1129772A (en) 1982-08-17
GB2031728A (en) 1980-04-30
EP0010437B1 (en) 1984-08-08
BE879471A (fr) 1980-04-18
EP0010437A2 (en) 1980-04-30
EP0010437A3 (en) 1981-05-13
AU529422B2 (en) 1983-06-09
IE791995L (en) 1980-04-20
CH642544A5 (fr) 1984-04-30
JPH0157097B2 (enrdf_load_stackoverflow) 1989-12-04
IE49086B1 (en) 1985-07-24
FR2439016A1 (fr) 1980-05-16
AU5179079A (en) 1980-04-24
GB2031728B (en) 1983-02-16
ZA795492B (en) 1981-05-27
JPS5557519A (en) 1980-04-28
FR2439016B1 (enrdf_load_stackoverflow) 1983-05-27
LU81799A1 (fr) 1980-01-25

Similar Documents

Publication Publication Date Title
ZA793542B (en) Pharmaceutical preparations
GB2085732B (en) Administration set
GB2039738B (en) Inflammation - preventing pharmaceutical composition
JPS55147223A (en) Pharmaceutical medicine
CS422079A2 (en) Rotacni bubnovy nebo kotoucovy filtr
GB2020655B (en) Pharmaceutical compounds
ZA787000B (en) Pharmaceutical formulation
NZ191847A (en) Stabilized pharmaceutical solutions of erythromycin
JPS54157817A (en) Pharmaceutical prepared solution
ZA7962B (en) Stabilized antibiotic formulations
DE2966178D1 (en) Compounds of the muramyl-peptide type and medicines containing them
JPS53130681A (en) Benzylpyrimidine compound*its production and medicines containing same
JPS54154516A (en) Pharmaceutical composition
JPS5524172A (en) Benzimidazole*its manufacture and pharmaceutic medicine containing it
GB2021558B (en) Antibiotic substance mycoplanecin
JPS5519257A (en) Medicine retard form
GB2028660B (en) Administration set
JPS54112851A (en) Aminoo33cardenolide derivatives*their manufacture and medicines containing them
JPS54138596A (en) Stabilized nicotineamideeadeninedinucleotide and its manufacture
GB2017079B (en) Substance sf-1739 derivatives
JPS5517396A (en) Pharmaceutic medicine
ZA79535B (en) Stabilised solutions
JPS54147911A (en) Pharmaceutical composition containing nnacetylmulaminate glycohydrorase
NZ192135A (en) Hydroxy-alkyl pyrid-2-yldithiocarbamates and pharmaceutical compositions
JPS5566521A (en) Manufacture of solid drug